LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- How Big Is The Targeted Alpha-Therapy Market In 2025? The market for targeted alpha-therapy has seen a significant surge ...

Psychological stress can impair the brain’s reward system, contributing to psychiatric disorders. A new study examines how a ...

For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says.

Early research suggests a brain test may predict whether antidepressants will cause sexual dysfunction. There has never been ...

Lilly to present new clinical data for Verzenio and multiple novel pipeline programMEs at the 2025 ESMO annual meeting: Indianapolis Tuesday, October 14, 2025, 09:00 Hrs [IST] Eli ...

Many patients with long COVID experience brain fog, but the reasons are not well understood. A new study links brain fog to a ...

FDA grants orphan drug designation to cintredekin besudotox, offering new hope for glioblastoma treatment with targeted ...

Immatics is advancing Anzu-cel, a T-cell receptor therapy for melanoma with potential for significant annual revenue. Learn ...

The FDA granted orphan drug designation to cintredekin besudotox for glioblastoma, supporting further research for this ...

Sanofi reports that its AlphaMedix phase 2 trial showed strong efficacy and survival benefits in gastroenteropancreatic ...

Harmony Biosciences Holdings faces setbacks after a failed trial and sNDA rejection. Click here to find out why HRMY is a Hold.